rs2838952
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001379500.1(COL18A1):c.3681C>T(p.Ile1227Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0319 in 1,604,708 control chromosomes in the GnomAD database, including 1,174 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.027 ( 88 hom., cov: 34)
Exomes 𝑓: 0.032 ( 1086 hom. )
Consequence
COL18A1
NM_001379500.1 synonymous
NM_001379500.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.73
Publications
5 publications found
Genes affected
COL18A1 (HGNC:2195): (collagen type XVIII alpha 1 chain) This gene encodes the alpha chain of type XVIII collagen. This collagen is one of the multiplexins, extracellular matrix proteins that contain multiple triple-helix domains (collagenous domains) interrupted by non-collagenous domains. A long isoform of the protein has an N-terminal domain that is homologous to the extracellular part of frizzled receptors. Proteolytic processing at several endogenous cleavage sites in the C-terminal domain results in production of endostatin, a potent antiangiogenic protein that is able to inhibit angiogenesis and tumor growth. Mutations in this gene are associated with Knobloch syndrome. The main features of this syndrome involve retinal abnormalities, so type XVIII collagen may play an important role in retinal structure and in neural tube closure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
SLC19A1 (HGNC:10937): (solute carrier family 19 member 1) The membrane protein encoded by this gene is a transporter of folate and is involved in the regulation of intracellular concentrations of folate. Three transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Mar 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (REVEL=0.086).
BP6
Variant 21-45510249-C-T is Benign according to our data. Variant chr21-45510249-C-T is described in ClinVar as Benign. ClinVar VariationId is 522315.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.73 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0706 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL18A1 | NM_001379500.1 | c.3681C>T | p.Ile1227Ile | synonymous_variant | Exon 40 of 42 | ENST00000651438.1 | NP_001366429.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0267 AC: 4059AN: 152202Hom.: 86 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
4059
AN:
152202
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0403 AC: 9068AN: 225060 AF XY: 0.0353 show subpopulations
GnomAD2 exomes
AF:
AC:
9068
AN:
225060
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0324 AC: 47108AN: 1452388Hom.: 1086 Cov.: 33 AF XY: 0.0314 AC XY: 22682AN XY: 722064 show subpopulations
GnomAD4 exome
AF:
AC:
47108
AN:
1452388
Hom.:
Cov.:
33
AF XY:
AC XY:
22682
AN XY:
722064
show subpopulations
African (AFR)
AF:
AC:
173
AN:
33212
American (AMR)
AF:
AC:
5665
AN:
43726
Ashkenazi Jewish (ASJ)
AF:
AC:
130
AN:
25950
East Asian (EAS)
AF:
AC:
8
AN:
39104
South Asian (SAS)
AF:
AC:
1714
AN:
84838
European-Finnish (FIN)
AF:
AC:
1414
AN:
51452
Middle Eastern (MID)
AF:
AC:
77
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
36442
AN:
1108364
Other (OTH)
AF:
AC:
1485
AN:
59984
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
2621
5242
7862
10483
13104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1434
2868
4302
5736
7170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0267 AC: 4071AN: 152320Hom.: 88 Cov.: 34 AF XY: 0.0271 AC XY: 2015AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
4071
AN:
152320
Hom.:
Cov.:
34
AF XY:
AC XY:
2015
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
318
AN:
41574
American (AMR)
AF:
AC:
1135
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
21
AN:
3470
East Asian (EAS)
AF:
AC:
3
AN:
5186
South Asian (SAS)
AF:
AC:
84
AN:
4830
European-Finnish (FIN)
AF:
AC:
259
AN:
10624
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2135
AN:
68012
Other (OTH)
AF:
AC:
52
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
207
414
620
827
1034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
38
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Oct 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Knobloch syndrome Benign:2
Jan 23, 2017
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.